Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000238520

Medchemexpress LLC Pamufetinib mesylate | 1688673-09-7 | 99.2% | 614.66 | C28H27FN4O7S2 | 25MG
SDP

Supplier:  Medchemexpress LLC HY12423A25MG

Encompass_Preferred

Pamufetinib mesylate is a research-stage small-molecule kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) and hepatocyte growth factor receptor (c-Met/HGFR). It exhibits low-nanomolar inhibition of recombinant VEGFR2 and MET and is used in preclinical studies of angiogenesis and MET-driven signaling in oncology research. The compound is provided as the mesylate salt for laboratory use and should be stored under controlled conditions to maintain stability.

  • Provides low-nanomolar inhibition of VEGFR2 and MET (IC50 ≈ 30-32 nM).
  • Suitable for preclinical studies of angiogenesis and MET-dependent signaling.
  • High chemical purity as confirmed by batch analysis (~99.2%).
  • Mesylate salt form for convenient laboratory handling.
  • Stable when stored under recommended conditions to preserve activity.

Catalog No. 50-002-38520


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.